» Articles » PMID: 24885383

Clinical Impact of Circulating MiR-133, MiR-1291 and MiR-663b in Plasma of Patients with Acute Myocardial Infarction

Overview
Journal Diagn Pathol
Publisher Biomed Central
Specialty Pathology
Date 2014 Jun 3
PMID 24885383
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acute myocardial infarction (AMI) is one of the leading causes for death in both developed and developing countries and it is the single largest cause of death in the United States, responsible for 1 out of every 6 deaths. The objective of this study was to determine microRNA (miRNA) expression in AMI and determine whether miR-133, miR-1291 and miR-663b could be measured in plasma as a biomarker for recurrence.

Methods: Patients with AMI and those without AMI were retrospectively recruited for a comparison of their plasma miR-133, miR-1291 and miR-663b expression.

Results: miR-133, miR-1291 and miR-663b levels were significantly overexpressed in AMI compared with Non-AMI. MiR-133 showed an AUC of 0.912, with a sensitivity of 81.1% and a specificity of 91.2%. The AUC for miR-1291 was 0.695, with a sensitivity of 78.4% and a specificity of 89.5%. The AUC for miR-663b was 0.611, with a sensitivity of 72.4% and a specificity of 76.5%.

Conclusions: This study demonstrated that the levels of miR-133, miR-1291 and miR-663b are associated with AMI. The potential of these miRNAs as biomarkers to improve patient stratification according to the risk of AMI and as circulating biomarkers for the AMI progonos warrants further study.

Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/8183629061241474.

Citing Articles

Exosomal mir-126-3p derived from endothelial cells induces ion channel dysfunction by targeting RGS3 signaling in cardiomyocytes: a novel mechanism in Takotsubo cardiomyopathy.

Fan X, Yang G, Wang Y, Shi H, Nitschke K, Sattler K Stem Cell Res Ther. 2025; 16(1):36.

PMID: 39901299 PMC: 11792229. DOI: 10.1186/s13287-025-04157-0.


Evidence and perspectives on miRNA, circRNA, and lncRNA in myocardial ischemia-reperfusion injury: a bibliometric study.

Bo X, Li Q, Chen S, Zhou T, Yin N, Song W J Cardiothorac Surg. 2025; 20(1):66.

PMID: 39815292 PMC: 11736979. DOI: 10.1186/s13019-024-03238-0.


Emerging Biomarkers of Acute Myocardial Infarction, An Overview of the Newest MicroRNAs.

Shahabi Raberi V, Javanshir E, Abbasnezhad M, Mashayekhi S, Abbasnezhad A, Ahmadzadeh M Galen Med J. 2024; 12:e2909.

PMID: 38774858 PMC: 11108668. DOI: 10.31661/gmj.v12i0.2909.


Exosomal miR-663b from "M1" macrophages promotes pulmonary artery vascular smooth muscle cell dysfunction through inhibiting the AMPK/Sirt1 axis.

Ma H, Yu Y, Mo L, Chen Q, Dong H, Xu Y Aging (Albany NY). 2023; 15(9):3549-3571.

PMID: 37142272 PMC: 10449306. DOI: 10.18632/aging.204690.


Screening of Biomarkers Related to Myocardial Infarction Based on the Construction of a ceRNA Regulation Network.

Ma P, Li J, Cheng M Anatol J Cardiol. 2023; 27(5):274-281.

PMID: 37119187 PMC: 10160844. DOI: 10.14744/AnatolJCardiol.2023.2388.


References
1.
Bi H, Yang Y, Huang J, Li Y, Ma C, Cong B . Immunohistochemical detection of S100A1 in the postmortem diagnosis of acute myocardial infarction. Diagn Pathol. 2013; 8:84. PMC: 3663776. DOI: 10.1186/1746-1596-8-84. View

2.
Zheng H, Wang Y, Lin J, Li N, Zhao X, Liu G . Circulating MicroRNAs as potential risk biomarkers for hematoma enlargement after intracerebral hemorrhage. CNS Neurosci Ther. 2012; 18(12):1003-11. PMC: 6493543. DOI: 10.1111/cns.12019. View

3.
Noichri Y, Chalghoum A, Chkioua L, Baudin B, Ernez S, Ferchichi S . Low erythrocyte catalase enzyme activity is correlated with high serum total homocysteine levels in Tunisian patients with acute myocardial infarction. Diagn Pathol. 2013; 8:68. PMC: 3651277. DOI: 10.1186/1746-1596-8-68. View

4.
Wang G, Zhu J, Zhang J, Li Q, Li Y, He J . Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010; 31(6):659-66. DOI: 10.1093/eurheartj/ehq013. View

5.
Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M . Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet. 2011; 4(4):446-54. DOI: 10.1161/CIRCGENETICS.110.958975. View